Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro

[1]  J. Witjes,et al.  Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin , 2005, Cancer Immunology, Immunotherapy.

[2]  T. Ishikawa,et al.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2 , 2005, Cancer Immunology, Immunotherapy.

[3]  L. Bergmann,et al.  Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2 , 2005, Cancer Immunology, Immunotherapy.

[4]  W. Fridman,et al.  Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity , 2005, Cancer Immunology, Immunotherapy.

[5]  F. Debruyne,et al.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer , 2005, Cancer Immunology, Immunotherapy.

[6]  I. Fidler,et al.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives , 1986, Cancer Immunology, Immunotherapy.

[7]  W. Catalona,et al.  Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review , 1985, World Journal of Urology.

[8]  J. Johnson,et al.  Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2 , 2004, Cancer Immunology, Immunotherapy.

[9]  S. Prescott,et al.  An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. , 1992, The Journal of urology.

[10]  R. Pollock,et al.  Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes. , 1991, Lymphokine and cytokine research.

[11]  H. Flad,et al.  Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines. , 1991, Immunology letters.

[12]  M. Lotze,et al.  IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. , 1991, Journal of immunology.

[13]  J. Smyth,et al.  Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. , 1990, The Journal of urology.

[14]  G. Adolf,et al.  Highly sensitive enzyme immunoassay for human lymphotoxin (tumor necrosis factor beta) in serum. , 1990, Journal of immunological methods.

[15]  M. Ernst,et al.  Autologous Regulation of rIL-2-Activated Natural Killer Cells , 1990 .

[16]  J. Gerdes,et al.  Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. , 1990, The Journal of urology.

[17]  J. Gerdes,et al.  Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. , 1990, The Journal of urology.

[18]  J. Gerdes,et al.  Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma. , 1990, Cytokine.

[19]  M. Schlaak,et al.  Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive modes of monocyte-mediated growth control. , 1990, Experimental cell research.

[20]  G. Semenzato.  Lymphokine activated killer cells: a new approach to immunotherapy of cancer. , 1990, Leukemia.

[21]  H. Findley,et al.  Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro. , 1990, Cancer investigation.

[22]  J. Ijzermans,et al.  Interferon-gamma: a review. , 1989, Immunobiology.

[23]  H. Flad,et al.  Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures. , 1989, Immunobiology.

[24]  M. Ernst,et al.  The effect of interleukin 2 on Fc-gamma receptor function of human monocytes requires specific intercellular interaction. , 1989, Immunobiology.

[25]  V. Laudone,et al.  An overview of intravesical therapy for superficial bladder tumors. , 1987, The Journal of urology.

[26]  K. Welte,et al.  Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor. , 1987, Journal of immunology.

[27]  W. Catalona,et al.  Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. , 1987, The Journal of urology.

[28]  J. Ortaldo,et al.  Lymphokine-activated killer cells. Analysis of progenitors and effectors , 1986, The Journal of experimental medicine.

[29]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[30]  G. Trinchieri,et al.  Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation , 1986, The Journal of experimental medicine.

[31]  H. Flad,et al.  Binding characteristics of a monoclonal antibody against human IL-2 and its application for IL-2 measurement. , 1986, Lymphokine research.

[32]  K. Nakamura.  Monocyte-mediated cytotoxicity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus Calmette-Guérin. , 1984, The Keio journal of medicine.

[33]  M. Ernst,et al.  Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. , 1984, Immunobiology.

[34]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[35]  D. Adams,et al.  Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. , 1981, Journal of immunology.

[36]  W. Leibold,et al.  75Se-release: a short and long term assay system for cellular cytoxicity. , 1979, Zeitschrift fur Immunitatsforschung. Immunobiology.

[37]  N. Axelsen,et al.  Antibody response in rabbits to immunization with Mycobacterium leprae , 1977, Infection and immunity.

[38]  L. Glasgow.  INTERFERON: A REVIEW. , 1965, The Journal of pediatrics.